Sunjae Bae1,2,3, Mara A McAdams-DeMarco1,2, Allan B Massie1,2, Jacqueline M Garonzik-Wang1, Josef Coresh2,3,4, Dorry L Segev1,2. 1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD. 2. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD. 3. Department of Biostatistics, Johns Hopkins School of Public Health, Baltimore, MD. 4. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Early steroid withdrawal (ESW) is a viable maintenance immunosuppression strategy in low-risk kidney transplant recipients. A low panel-reactive antibody (PRA) may indicate low-risk condition amenable to ESW. We aimed to identify the threshold value of PRA above which ESW may pose additional risk and to compare the association of ESW with transplant outcomes across PRA strata. METHODS: We studied 121 699 deceased-donor kidney-only recipients in 2002-2017 from Scientific Registry of Transplant Recipients. Using natural splines and ESW-PRA interaction terms, we explored how the associations of ESW with transplant outcomes change with increasing PRA values and identified a threshold value for PRA. Then, we assessed whether PRA exceeding the threshold modified the associations of ESW with 1-y acute rejection, death-censored graft failure, and death. RESULTS: The association of ESW with acute rejection exacerbated rapidly when PRA exceeded 60. Among PRA ≤60 recipients, ESW was associated with a minor increase in rejection (adjusted odds ratio [aOR], 1.001.051.10) and with a tendency of decreased graft failure (adjusted hazard ratio [aHR], 0.910.971.03). However, among PRA >60 recipients, ESW was associated with a substantial increase in rejection (aOR, 1.191.271.36; interaction P < 0.001) and with a tendency of increased graft failure (aHR, 0.981.081.20; interaction P = 0.028). The association of ESW with death was similar between PRA strata (PRA ≤60, aHR, 0.910.961.01; and PRA >60, aHR, 0.900.991.09; interaction P = 0.5). CONCLUSIONS: Our findings show that the association of ESW with transplant outcomes is less favorable in recipients with higher PRA, especially those with PRA >60, suggesting a possible role of PRA in the risk assessment for ESW.
BACKGROUND: Early steroid withdrawal (ESW) is a viable maintenance immunosuppression strategy in low-risk kidney transplant recipients. A low panel-reactive antibody (PRA) may indicate low-risk condition amenable to ESW. We aimed to identify the threshold value of PRA above which ESW may pose additional risk and to compare the association of ESW with transplant outcomes across PRA strata. METHODS: We studied 121 699 deceased-donor kidney-only recipients in 2002-2017 from Scientific Registry of Transplant Recipients. Using natural splines and ESW-PRA interaction terms, we explored how the associations of ESW with transplant outcomes change with increasing PRA values and identified a threshold value for PRA. Then, we assessed whether PRA exceeding the threshold modified the associations of ESW with 1-y acute rejection, death-censored graft failure, and death. RESULTS: The association of ESW with acute rejection exacerbated rapidly when PRA exceeded 60. Among PRA ≤60 recipients, ESW was associated with a minor increase in rejection (adjusted odds ratio [aOR], 1.001.051.10) and with a tendency of decreased graft failure (adjusted hazard ratio [aHR], 0.910.971.03). However, among PRA >60 recipients, ESW was associated with a substantial increase in rejection (aOR, 1.191.271.36; interaction P < 0.001) and with a tendency of increased graft failure (aHR, 0.981.081.20; interaction P = 0.028). The association of ESW with death was similar between PRA strata (PRA ≤60, aHR, 0.910.961.01; and PRA >60, aHR, 0.900.991.09; interaction P = 0.5). CONCLUSIONS: Our findings show that the association of ESW with transplant outcomes is less favorable in recipients with higher PRA, especially those with PRA >60, suggesting a possible role of PRA in the risk assessment for ESW.
Authors: Mysore S Anil Kumar; Michael Heifets; Michael J Moritz; Muhammad I Saeed; Shahid M Khan; Billie Fyfe; Nedjema Sustento-Riodeca; Joshua N Daniel; Aparna Kumar Journal: Transplantation Date: 2006-03-27 Impact factor: 4.939
Authors: T B Dunn; H Noreen; K Gillingham; D Maurer; O G Ozturk; T L Pruett; R A Bray; H M Gebel; A J Matas Journal: Am J Transplant Date: 2011-08-03 Impact factor: 8.086
Authors: Krista L Lentine; Adrian Gheorghian; David Axelrod; Anu Kalsekar; Gilbert L'italien; Mark A Schnitzler Journal: Transplantation Date: 2012-08-27 Impact factor: 4.939
Authors: Sunjae Bae; Jacqueline M Garonzik Wang; Allan B Massie; Kyle R Jackson; Mara A McAdams-DeMarco; Daniel C Brennan; Krista L Lentine; Josef Coresh; Dorry L Segev Journal: J Am Soc Nephrol Date: 2019-12-18 Impact factor: 10.121
Authors: R D Gordon; J J Fung; B Markus; I Fox; S Iwatsuki; C O Esquivel; A Tzakis; S Todo; T E Starzl Journal: Surgery Date: 1986-10 Impact factor: 3.982
Authors: Arthur J Matas; Raja Kandaswamy; Abhinav Humar; William D Payne; David L Dunn; John S Najarian; Rainer W G Gruessner; Kristen J Gillingham; Lois E McHugh; David E R Sutherland Journal: Ann Surg Date: 2004-09 Impact factor: 12.969
Authors: Giuseppe Montagnino; Silvio Sandrini; Beniamino Iorio; Francesco Paolo Schena; Mario Carmellini; Paolo Rigotti; Maria Cossu; Paolo Altieri; Maurizio Salvadori; Sergio Stefoni; Giuseppe Corbetta; Claudio Ponticelli Journal: Nephrol Dial Transplant Date: 2007-09-21 Impact factor: 5.992
Authors: Bernhard K Krämer; Marian Klinger; Štefan Vítko; Maciej Glyda; Karsten Midtvedt; Sergio Stefoni; Franco Citterio; Frank Pietruck; Jean-Paul Squifflet; Giuseppe Segoloni; Bernd Krüger; Heide Sperschneider; Bernhard Banas; Lars Bäckman; Markus Weber; Mario Carmellini; Ferenc Perner; Kerstin Claesson; Wojciech Marcinkowski; Marek Ostrowski; Grzegorz Senatorski; Johan Nordström; Kaija Salmela Journal: Transplantation Date: 2012-09-15 Impact factor: 4.939